Loading...
Asymptomatic mitral regurgitation (MR) presents a dilemma: We'd like to avoid surgery in asymptomatic patients, but outcomes might be worse if we wait for heart failure to occur. This prospective observational study from Mayo Clinic provides some guidance.
Researchers followed 456 patients (mean age, 63) with initially asymptomatic primary MR due to diseased valve leaflets (as opposed to MR secondary to dilated cardiomyopathy or ischemia); 80% had mitral valve prolapse. Effective regurgitant orifice (determined by echocardiography) was the best predictor of adverse outcomes. Even with medical management, patients with orifices of ≥40 mm2 and those with orifices of 20 mm2 to 39 mm2 had significantly reduced 5-year survival compared with expec…